Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$0.39 - $0.88 $34 - $78
89 New
89 $0
Q1 2023

May 12, 2023

BUY
$0.85 - $1.41 $1,541 - $2,557
1,814 Added 40.07%
6,341 $7,000
Q4 2022

Feb 08, 2023

SELL
$0.79 - $1.49 $624 - $1,178
-791 Reduced 14.87%
4,527 $3,000
Q3 2022

Nov 10, 2022

BUY
$1.32 - $3.76 $7,019 - $19,995
5,318 New
5,318 $7,000

Others Institutions Holding HSTO

# of Institutions
1
Shares Held
17
Call Options Held
0
Put Options Held
0

About Histogen Inc.


  • Ticker HSTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,497,450
  • Market Cap $549K
  • Description
  • Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media...
More about HSTO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.